Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study-Reference-Cited by-同舟云学术

Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross-sectional study

Published:2018-10-01 Issue:22 Volume:175 Page:4229-4238
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Langhof Holger¹²^ORCID,Chin William Wei Lim²,Wieschowski Susanne²,Federico Carole³,Kimmelman Jonathan³,Strech Daniel¹²

Affiliation:

1. Charité - University Medicine Berlin, QUEST - Center for Transforming Biomedical Research; Berlin Institute of Health (BIH); Berlin Germany

2. Institute for History, Ethics and Philosophy of Medicine; Hannover Medical School (MHH); Hannover Germany

3. STREAM (Studies of Translation, Ethics and Medicine), Biomedical Ethics Unit; McGill University; Montreal QC Canada

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14485/fullpdf

Reference49 articles.

1. Drug development: raise standards for preclinical cancer research;Begley;Nature,2012

2. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group;Bellomo;Crit Care,2004

3. Myocardial protection at a crossroads: the need for translation into clinical therapy;Bolli;Circ Res,2004

4. Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy;Bolon;Biomed Res Int,2010

5. The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias;Curtis;Pharmacol Ther,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs;Translational Psychiatry;2023-03-01

2. Mechanism-Driven and Clinically Focused Development of Botanical Foods as Multitarget Anticancer Medicine: Collective Perspectives and Insights from Preclinical Studies, IND Applications and Early-Phase Clinical Trials;Cancers;2023-01-23

3. Toward 3D‐Bioprinted Models of the Liver to Boost Drug Development;Macromolecular Bioscience;2022-09-22

4. Preclinical efficacy in investigator's brochures: Stakeholders' views on measures to improve completeness and robustness;British Journal of Clinical Pharmacology;2022-08-31

5. Preclinical Efficacy in Investigator’s Brochures: Stakeholders’ views on measures to improve Completeness and Robustness;2022-02-08